Drug Trial Radar · NCT03913923
Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma
Last checked: Nov 19, 2026Latest source record: Feb 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
117
Actual
Start
Jul 1, 2019
Primary completion
Jul 2023
Study completion Dec 2023
Sponsor
- Lead sponsor
- BiocadIndustry
- Sponsor type
- Industry
- First posted
- Apr 12, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter randomized double-blind placebo-controlled phase II clinical trial. The purpose of this trial is to evaluate efficacy and safety of therapy consisting of BCD-217 (fixed dose combination of anti-CTLA-4 and anti-PD-1 monoclonal antibodies) and sequential BCD-100 (anti-PD-1 monoclonal antibody) versus BCD-100 monotherapy as first-line treatment in patients with treatment-naïve unresectable or metastatic melanoma.
Conditions
- Melanoma
- Melanoma Metastatic
Interventions
BCD-217Biological
Combination of anti-CTLA-4 and anti-PD-1 monoclonal antibodies, 1mg/kg and 3 mg/mg, respectively, given Q3W as IV infusion for first 4 blinded infusions
BCD-100Biological
Anti-PD-1 monoclonal antibody, 3 mg/kg, given Q3W as IV infusion for first 4 blinded infusions, after - 1 mg/kg, given Q2W as IV infusion
PlaceboOther
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Median Progression-Free SurvivalTime frame: 2 years
Locations
23 sites in 2 countries. Site status is shown where the registry gives one.
Healthcare Institution "Minsk Municipal Clinical Oncolo-gy Dispensary" (MMCOD)
Minsk, Belarus
State Institution "N.N. Aleksandrov Republican Research and Practical Center for Oncology and Medical Radiology"
The Settlement of Lesnoy, Minsk District, Belarus
State Budgetary Healthcare Institution of the Ar-khangelsk Region "Arkhangelsk Clinical Oncology Dispensary"
Arkhangelsk, Russia
Territorial State Budgetary Healthcare Institution "Altai Territorial Clinical Oncology Dispensary"
Barnaul, Russia
State Budgetary Healthcare Institution "Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine",
Chelyabinsk, Russia
State public health institution "Republican Clinical Oncology Dispensary" of the Ministry of Health of the Republic of Tatarstan
Kazan', Russia
Regional State Budgetary of Healthcare Insti-tution "Kostroma Oncology Dispensary"
Kostroma, Russia
Medsi Group of Companies Joint-Stock Company
Moscow, Russia
"Russian Cancer Research Center named after N.N. Blokhin "of the Ministry of Health of the Russian Federation
Moscow, Russia
State Health Care Institution "Moscow City Oncology Hospital № 62" Moscow Health Department
Moscow, Russia
State Budgetary Healthcare Institution of the Novosi-birsk Region "Novosibirsk Regional Clinical Oncolo-gy Dispensary"
Novosibirsk, Russia
State budget healthcare institution Omsk region "Clinical Oncology Dispensary"
Omsk, Russia
JSC "Modern Medical Technologies"
Saint Petersburg, Russia
AV Medical Group Limited Liability Company
Saint Petersburg, Russia
Federal State Institution "N.N. Petrov National Medical Research Center for Oncology"
Saint Petersburg, Russia
Saint-Petersburg Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)
Saint Petersburg, Russia
Federal State Budgetary Educational Institution of Higher Education "St. Petersburg State University"
Saint Petersburg, Russia
State-financed Health Institution "Samara Region Clinical Oncology Dispansary"
Samara, Russia
Clinical Oncologic Dispensary No. 2
Sochi, Krasnodar Territory, Russia
Krasnoyarsk Regional Clinical Oncological Dispensary named after A.I. Kryzhanovsky
Krasnoyarsk, Krasnoyarsk Krai, Russia
Murmansk Regional Clinical Hospital named after P.A. Bayandina
Murmansk, Murmansk Oblast, Russia
LLC "New Clinic"
Pyatigorsk, Stavropol Kray, Russia
Regional Clinical Oncology Hospital
Yaroslavl, Yaroslavl Oblast, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.